Procurement Summary
Country : USA
Summary : “Acceleration of Deployment Readiness through First Line Oral Appliance Therapy for Obstructive Sleep Apnea (OSA)”
Deadline : 08 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 121432604
Document Ref. No. : HT9425-25-NOI-TNM01
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
NOTICE OF INTENT TO SOLE SOURCE:
This is a Notice of Intent to Sole Source award on the basis of other than full and open competition in accordance with the Federal Acquisition (FAR) 6.302-1, as the unique services are only available from one source and awarding to any other source would not fulfill the agency-s requirements. This is not a request for Quotes or Proposals. No contract award will be made on the basis of the responses to this notice. The purpose of this notice is to allow interested parties to assert and explain their capability to perform the work described.
The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at 808 Schreider Street, Fort Detrick, MD on behalf of the Defense Health Agency (DHA) 59th Medical Wing, Science and Technology (59MDW/ST) Office located at Joint Base San Antonio, Lackland Air Force Base, Texas intends to award a sole source firm fixed price contract to Central Texas Veterans Research Foundation (CTVRF) to provide research for a study titled “Acceleration of Deployment Readiness through First Line Oral Appliance Therapy for Obstructive Sleep Apnea (OSA)”.
PROGRAM DESCRIPTION:
The DHA 59MDW/ST Office has a requirement for research and development (R&D) services. A significant number of Soldiers were diagnosed with OSA from 2014 to 2019, significantly affecting cognitive function, reaction time, and behavioral health. These numbers continue to increase each year, and these Soldiers remain non-deployable until the course of treatment produces a resolution of symptoms including excessive daytime sleepiness.
Veteran Affairs (VA) and Department of Defense (DoD) guidelines recommend either Oral Appliance Therapy (OAT) or Positive Airway Pressure (PAP) therapy as first line options to manage obstructive sleep apnea (OSA). However, little guidance is provided on when to favor one therapy over the other and many VA and DoD clinicians only prescribe PAP as first line therapy. PAP thera...
Active Contract Opportunity
Notice ID : HT9425-25-NOI-TNM01
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: ARMY MED RES ACQ ACTIVITY
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Jun 23, 2025 03:30 pm EDT
Original Response Date: Jul 08, 2025 01:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 23, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; ExPERIMENTAL DEVELOPMENT
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: Temple, Tx 76504 USA
Documents
Tender Notice